/Companies

Toku

Founded 2019 · 21 employees on LinkedIn · 17 known investors

Find your way into Toku

Sign up to see every warm intro you have to Toku

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Toku team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Toku Eyes develops AI-driven solutions for eye health diagnostics and monitoring, bringing together medical expertise in endocrinology and ophthalmology with artificial intelligence capabilities.

Founders & leadership

MVMichael V. McConnell
Michael V. McConnellChief Health Officer and Interim CEO
FL
Francesca LoganChief Commercial Officer
YL
Yariv LevinChief Compliance, Ethics and Clinical Affairs Officer

Investors · 17

Also in the syndicate · 2

ClocktowerOrrick

Funding

SEC filings, press & company announcements

$57.3M disclosed across 2 of 3 rounds · 2023–2025

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Toku do?
Toku Eyes develops AI-driven solutions for eye health diagnostics and monitoring, bringing together medical expertise in endocrinology and ophthalmology with artificial intelligence capabilities.
Who are Toku's investors?
Toku's investors include Arc Angels, Icehouse Ventures, Outset Ventures, Blockchain Capital, F-Prime Capital, Funders Club Management, gmjp, Gradient Ventures and 7 more.
How much funding has Toku raised?
Toku has disclosed $57.3M raised across 2 of its 3 known rounds.